For Patients

For-Patients-BellHow can we help? As you progress towards graduating from your personalized Hope cancer treatment program, remember, we are here for you, day and night. If you have questions, don’t hesitate to ask. Have concerns, requests or just want to talk? Our staff makes it their mission to provide you with the care you require, including a healthy dose of conversation.

Not only does Hope Cancer Care of Nevada provide our family of patients with leading cancer care, we also provide natural, holistic alternative treatments for an all-encompassing treatment program. From aromatherapy to Reiki massage specialists, these organic amenities are designed to support your primary medical treatment while providing an increased positive impact on your mind, body and spirit. These services are here at your discretion and may be recommended by your oncologist, for more information see The Hope Touch.

Treating the whole patient is the driving force behind Hope Cancer Care of Nevada, which includes generating a strong caregiver support system. Throughout your treatment, your caregiver may access our “For Caregivers” portal where they can obtain more information on how to best aid in your recovery. They will also have a direct link to your oncologist should questions arise. We understand that your caregiver plays a vital role in not only your healing, but your comfort as well.

If you are new to our family, take a moment to become more acquainted with Hope Cancer Care of Nevada by visiting our “Before You Arrive” page.

 

slide_0

Norman Sharpless sworn in as director of the National Cancer Institute

10/18/17

Norman E. “Ned” Sharpless, M.D., becomes the 15th director of the National Cancer Institute (NCI). He comes to NCI from the University of North Carolina School of Medicine, where he was director of the Lineberger Comprehensive Cancer Center. …read more … Read More


Behind the numbers: cancers associated with obesity

10/03/17

By David Sampson A report out today had a lot of us scratching our heads, when it said that about 630,000 people in the U.S. were diagnosed with a cancer associated with overweight and obesity in 2014. That sounds awfully … Read More


NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers

09/26/17

TMIST, the first randomized trial comparing two types of digital mammography for breast cancer screening, is enrolling participants. Developed by ECOG-ACRIN and NCI, the trial is comparing 2-D and 3-D mammography for finding breast cancers. …read more Source:: Cancer


NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

09/06/17

Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines. …read more Source:: Cancer


New Analysis Confirms Suspected Bias of Large U.S. Prostate Screening Study

09/05/17

By David Sampson A new paper appearing in Annals of Internal Medicine used simulation modeling to try to correct for a known bias in a notable U.S. trial of prostate cancer screening, called PLCO. That study along with a large … Read More


NCI study identifies essential genes for cancer immunotherapy

08/07/17

A new NCI study identifies genes in cancer cells that are necessary for them to be killed by T cells, and therefore could be partially responsible for why immunotherapy doesn’t work in some patients. …read more Source:: Cancer


NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome

08/03/17

A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers. …read more Source:: Cancer


NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

07/24/17

The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations. …read more Source:: Cancer


TCGA study of liver cancer reveals potential targets for therapy

06/15/17

Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist. …read more Source:: … Read More


Don’t Fry Day: Getting Sunscreen Right

05/25/17

By David Sampson Despite increased awareness about the dangers of ultraviolet (UV) radiation, melanoma rates continue to rise in the United States. For “Don’t Fry Day” on May 26, the American Cancer Society is cautioning that many people may be … Read More